New facility increases Clinic’s capacity to analyze patient samples, advance medical research and enhance clinical care

Chelmsford, Mass., and Cleveland, Ohio – Cleveland Clinic and Brooks Automation. Inc. (Nasdaq: BRKS) will launch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of human tissue samples and advance personalized medicine for an array of conditions – including cancer, heart disease, and epilepsy.

This state-of-the-art facility will increase Cleveland Clinic’s existing biobanking capacity and accelerate translational research through streamlined patient consent processes and centralized storage.

“This new biorepository will be a critical resource for our scientists. Biobanking is essential for the evolution of personalized medicine. The ability to properly manage biological specimens and to compare diseased tissues side-by-side with healthy tissues, is essential to understanding the biological basis of a disease,” said Serpil Erzurum, MD, chair of Cleveland Clinic Lerner Research Institute. “As a leading healthcare organization, this provides an unparalleled opportunity to advance understanding of many different diseases, enabling us to make discoveries that are directly benefitting our patients.”

The two-story building will be located on the Cleveland Clinic’s campus and is expected to be completed in summer 2019. Brooks Life Sciences, a division of Brooks Automation and a global leader in sample management solutions, will manage the onsite operations to include storing and maintaining high-value collections of biological material safely and efficiently. They will begin with the launch of a sample inventory process that will annotate each sample within the storage facility before moving material to the new biorepository.

“With an international reputation as a leader in medical research, Cleveland Clinic understands the value sample management plays in medicalresearch and is committed to improving patient outcomes,” said Brooks Life Sciences President Dusty Tenney. “We are extremely proud to be partnering with Cleveland Clinic to manage the operations of its new biobank and to offer our expertise in sample management.”

About Brooks Automation, Inc.

Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. Brooks’ technologies, engineering competencies and global service capabilities provide customers speed to market and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments.  Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market.  Since 2011, Brooks has applied its automation and cryogenics expertise to meet the sample storage needs of customers in the life sciences industry.  Brooks Life Sciences, a division of Brooks Automation, provides a broad range of products and services for on-site infrastructure for sample management in temperatures of ‑20°C to -150°C, as well as comprehensive outsource service solutions across the complete life cycle of biological samples including collection, transportation, processing, storage, protection, retrieval and disposal that accelerate research and improve patient health.  Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, visit www.brooks.com